LNSR
LNSR
NASDAQ · Health Care

Lensar Inc

$6.88
-0.04 (-0.58%)
As of Sep 28, 10:19 PM ET ·
Financial Highlights (FY 2026)
Revenue
58.11M
Net Income
-34,086,939
Gross Margin
46.4%
Profit Margin
-58.7%
Rev Growth
+18.2%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 46.4% 46.4% 57.4% 57.4%
Operating Margin -42.1% -37.9% 10.3% 10.3%
Profit Margin -58.7% -55.7% 9.6% 8.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 58.11M 49.15M 55.38M 51.89M
Gross Profit 26.97M 22.81M 31.77M 29.77M
Operating Income -24,439,409 -18,603,965 5.73M 5.35M
Net Income -34,086,939 -25,947,936 5.32M 4.60M
Gross Margin 46.4% 46.4% 57.4% 57.4%
Operating Margin -42.1% -37.9% 10.3% 10.3%
Profit Margin -58.7% -55.7% 9.6% 8.9%
Rev Growth +18.2% +18.2% +8.2% -2.4%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 15.51M 16.29M
Total Equity — — 70.64M 78.05M
D/E Ratio — — 0.22 0.21
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -23,523,281 -18,901,393 9.24M 7.86M
Free Cash Flow — — 5.04M 4.51M